Search research articles
Contact Us
Filters
Showing results (71-80 of 272) with videos related to
Page
of 28
Sort By:
Journal of Pharmaceutical and Biomedical Analysis
|
June 4, 2021
Simultaneous LC-MS/MS quantification of oxycodone, tramadol and fentanyl and their metabolites (noroxycodone, oxymorphone, O- desmethyltramadol, N- desmethyltramadol, and norfentanyl) in human plasma and whole blood collected via venepuncture and volumetric absorptive micro sampling
Aymen A Al-Qurain, Desmond B Williams, Lorraine Mackenzie, et al.
Trauma Surgery & Acute Care Open
|
July 18, 2024
Opioid and non-opioid analgesic regimens after fracture and risk of serious opioid-related events
Kyle Hart, Andrew J Medvecz, Avi Vaidya, et al.
British Journal of Clinical Pharmacology
|
January 27, 2016
A model-based evaluation of single metrics for discriminating changes in rheumatoid arthritis disease activity
Jessica Wojciechowski, Michael D Wiese, Susanna M Proudman, et al.
Pharmacological Research
|
June 12, 2018
Intrauterine growth restriction may reduce hepatic drug metabolism in the early neonatal period
Jia Yin Soo, Michael D Wiese, Mary J Berry, et al.
The Annals of Pharmacotherapy
|
November 12, 2014
Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors
Emily Reeve, Jane M Andrews, Michael D Wiese, et al.
British Journal of Clinical Pharmacology
|
November 14, 2014
A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine
Jessica Wojciechowski, Michael D Wiese, Susanna M Proudman, et al.
Pharmacogenomics and Personalized Medicine
|
December 7, 2018
Genetic polymorphism of the methotrexate transporter ABCG2, blood pressure and markers of arterial function in patients with rheumatoid arthritis: repeated cross-sectional study
Leena R Baghdadi, Richard J Woodman, E Michael Shanahan, et al.
Pharmacoepidemiology and Drug Safety
|
February 16, 2013
The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection
Izyan A Wahab, Nicole L Pratt, Michael D Wiese, et al.
Journal of Developmental Origins of Health and Disease
|
January 25, 2021
COVID-19: can we treat the mother without harming her baby?
Michael D Wiese, Mary J Berry, Pravin Hissaria, et al.
The AAPS Journal
|
April 27, 2017
Infliximab Maintenance Dosing in Inflammatory Bowel Disease: an Example for In Silico Assessment of Adaptive Dosing Strategies
Jessica Wojciechowski, Richard N Upton, Diane R Mould, et al.
Page
of 28
Search research articles
Search
Showing results (71-80 of 272) with videos related to
Sort By:
Page
of 28
Journal of Pharmaceutical and Biomedical Analysis
|
June 4, 2021
Simultaneous LC-MS/MS quantification of oxycodone, tramadol and fentanyl and their metabolites (noroxycodone, oxymorphone, O- desmethyltramadol, N- desmethyltramadol, and norfentanyl) in human plasma and whole blood collected via venepuncture and volumetric absorptive micro sampling
Aymen A Al-Qurain, Desmond B Williams, Lorraine Mackenzie, et al.
Trauma Surgery & Acute Care Open
|
July 18, 2024
Opioid and non-opioid analgesic regimens after fracture and risk of serious opioid-related events
Kyle Hart, Andrew J Medvecz, Avi Vaidya, et al.
British Journal of Clinical Pharmacology
|
January 27, 2016
A model-based evaluation of single metrics for discriminating changes in rheumatoid arthritis disease activity
Jessica Wojciechowski, Michael D Wiese, Susanna M Proudman, et al.
Pharmacological Research
|
June 12, 2018
Intrauterine growth restriction may reduce hepatic drug metabolism in the early neonatal period
Jia Yin Soo, Michael D Wiese, Mary J Berry, et al.
The Annals of Pharmacotherapy
|
November 12, 2014
Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors
Emily Reeve, Jane M Andrews, Michael D Wiese, et al.
British Journal of Clinical Pharmacology
|
November 14, 2014
A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine
Jessica Wojciechowski, Michael D Wiese, Susanna M Proudman, et al.
Pharmacogenomics and Personalized Medicine
|
December 7, 2018
Genetic polymorphism of the methotrexate transporter ABCG2, blood pressure and markers of arterial function in patients with rheumatoid arthritis: repeated cross-sectional study
Leena R Baghdadi, Richard J Woodman, E Michael Shanahan, et al.
Pharmacoepidemiology and Drug Safety
|
February 16, 2013
The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection
Izyan A Wahab, Nicole L Pratt, Michael D Wiese, et al.
Journal of Developmental Origins of Health and Disease
|
January 25, 2021
COVID-19: can we treat the mother without harming her baby?
Michael D Wiese, Mary J Berry, Pravin Hissaria, et al.
The AAPS Journal
|
April 27, 2017
Infliximab Maintenance Dosing in Inflammatory Bowel Disease: an Example for In Silico Assessment of Adaptive Dosing Strategies
Jessica Wojciechowski, Richard N Upton, Diane R Mould, et al.
Page
of 28